Nesa Medtech
Coimbatore, India· Est.
Innovative scar‑less device for uterine fibroid treatment, preserving the uterus and shortening recovery.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Innovative scar‑less device for uterine fibroid treatment, preserving the uterus and shortening recovery.
Gynecology
Technology Platform
A precise image‑guided planning and delivery system that enables scar‑less, minimally invasive treatment of uterine fibroids while preserving uterine integrity.
Opportunities
Growing demand for uterus‑preserving, outpatient fibroid treatments and potential cost advantages in low‑resource settings.
Risk Factors
Regulatory approval uncertainty and competition from established surgical and interventional fibroid therapies.
Competitive Landscape
Competes with surgical myomectomy, hysterectomy, UAE, and MRgFUS; differentiation hinges on scar‑less, faster recovery and reduced infrastructure needs.